2019
DOI: 10.1016/j.ijpharm.2019.118500
|View full text |Cite
|
Sign up to set email alerts
|

Antibacterial and transfection activities of nebulized formulations incorporating long n-alkyl chain silver N-heterocyclic carbene complexes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
9
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
5
2

Relationship

1
6

Authors

Journals

citations
Cited by 19 publications
(9 citation statements)
references
References 48 publications
0
9
0
Order By: Relevance
“…The aerosol delivery was performed using an unrestrained whole-body exposure protocol with the PARI LC PLUS nebulizer (PARI, Starnberg, Germany), which has been tested and proven in many clinical trials (Figure 3; see also Figure S1 for more details about the experimental set-up) [8,9]. For each aerosol experiment, 15 to 20 mice were introduced into the exposure box.…”
Section: Aerosol Deliverymentioning
confidence: 99%
See 2 more Smart Citations
“…The aerosol delivery was performed using an unrestrained whole-body exposure protocol with the PARI LC PLUS nebulizer (PARI, Starnberg, Germany), which has been tested and proven in many clinical trials (Figure 3; see also Figure S1 for more details about the experimental set-up) [8,9]. For each aerosol experiment, 15 to 20 mice were introduced into the exposure box.…”
Section: Aerosol Deliverymentioning
confidence: 99%
“…The main lipidic formulations considered in the present study (F1 to F20, Table 2) were noted as "F# + L" or "F# + C", the letters "L" and "C" referring to the luciferase-encoding (pGM144) and the CFTR-encoding (pCIK-CFTR) pDNA, respectively. 1 Lipid formulation (F#) mixed with the luciferase-encoding pDNA pGM144 (L); 2 in addition to DP5K; 3 cationic lipid/colipid(s) molar ratio; 4 DP5K/pDNA mass ratio; 5 cationic lipid/pDNA charge ratio; 6 in nm; 7 polydispersity index; 8 in mV; 9 relative lung reporter gene expression on day 1 (D1), 7 (D7) and 14/28 (D28) (the minimal luciferase expression being given the value of 1) and classification according to the maximal luciferase expression (MLE) reached (on average on day 1, 7, or 14/28), as follows: Gr1 (inefficient), MLE ≤ 10 3 ; Gr2 (slightly efficient), MLE ≤ 10 4 ; Gr3 (efficient), MLE ≤ 10 5 ; Gr4 (most efficient), MLE ≤ 10 6 RLU/mg protein (Figure 4). For naive mice, the luminescence signal measured was ~10 2 RLU/mg protein.…”
Section: All Lipidic Formulations Were Not Stable When Mixed With Highly Concentrated Pdnamentioning
confidence: 99%
See 1 more Smart Citation
“…103 A study presented that nano-articulated silver carbene complexes enveloped have harmful affect for MDR bacteria involving P. aeruginosa, K. pneumoniae, MRSA, Acinetobacter baumannii (A. baumannii) and Burkholderia cepacia. 104 Ag-NM has been revealed to ensure antiviral action against HBV and HIV-1. 105 Zinc Oxide Nanomaterials (ZnO-NMs) Different tools are being utilized by ZnO-NMs to tackle microbes and making the resistant unlikely.…”
Section: Metallic Nanomaterials (Metallic-nms)mentioning
confidence: 99%
“…One of the examples is SCC's comprising L-Tyrosine polyphosphate NMs (LTP-NMs). 104 In vitro, antimicrobial action against C. albicans, B. cepacia, P. aeruginosa, MRSA, K. pneumoniae, and multidrug-resistant A. baumannii (MRAB) is shown by SCCs loaded into LTP-NMs and free SCCs. 18 Hindi et al studied that two inhaled doses administered about 72 hours of SCCs comprising LTP-NMs lower bacterial load in the lung, minimize bacteremia, and high survival by 25% in mouse models with P. aeruginosa pneumoniae.…”
Section: Nms Combating Intracellular Bacteriamentioning
confidence: 99%